About this trial
The RESPOND trial explores the link between early life adversity and later life depressive symptoms. The investigators have designed a new psychological therapy tailored to address the symptoms that can be caused by difficult experiences in early life. These symptoms include low mood, emotional dysregulation, and distressing thoughts and beliefs related to difficult or traumatic experiences. The investigators would like to see if this new therapy helps people feel better. The investigators are also studying the biological changes that can occur as a result of early life adversity, and how this therapy may influence those changes. To do this, the investigators ask questions about participants' physical and mental health and take blood samples.
Eligibility criteria
Qualifiers
Adults 18 years old or older
At or above 18 on HAM-D, indicative of moderate-severe depressive symptoms
Any childhood (before 18 years old) adversity as indicated by scores on the CECA q and ACES q
Disqualifiers
Individuals who meet for PTSD diagnosis from a criterion A trauma occurring in adulthood without a history of ELA
Individuals experiencing active mania or psychosis
Individuals with an active substance use disorder
Individuals presenting with active suicide risk (plan, intention, means) indicative of a need for higher level care
Trial design
Treatments tested in this trial
- Psychotherapy
Treatment groups
Sponsors and collaborators
St. Joseph's Healthcare Hamilton
Lead sponsor
Sun Life Financial Movement Disorders Research and Rehabilitation Centre
Collaborator